Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1600)

Milan, Milano 20133

1 studies enrolling now · 1 studies all time

What they study most

Renal Cell Carcinoma

Studies at this site

• A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) — Recruiting now